Current Management of Moderate-to-Severe Atopic Dermatitis: A Survey of Allergists, Pediatric Allergists and Dermatologists in Korea

摘要: Purpose There is an unmet need for the treatment of moderate-to-severe atopic dermatitis (AD), leading to variation in management strategies. To investigate distinct features and modalities according physicians' specialties, we collected data on current approach AD among allergists, pediatric allergists dermatologists Korea. Methods This questionnaire-based study was administered physicians from Korean Academy Asthma, Allergy Clinical Immunology (KAAACI), Pediatric Respiratory Disease (KAPARD), Atopic Dermatitis Association (KADA). Results A total 93 participated study; 64.5% were 31.2% dermatologists. The major patient age groups "less than 5 years" 100% "6-12 years old" 38% proportion patients with higher compared allergists. Physicians agreed necessity education including demonstration basic skin care application topical therapies (88.2%), nutritional consultation (83.9%) psychological counseling (75.3%). However, less half able educate counsel their real practice. noticeable differences first-line physician groups. For order preferred systemic wet wrap therapy, corticosteroids oral cyclosporin. Dermatologists ranked cyclosporin, phototherapy, as regimens. Major reported barriers proper steroid phobia, unproven complementary alternative medicine, lack education, unreasonable insurance system. Conclusions Our findings suggest there are specialties. Medical policy changes along governmental supports required implement ideal AD, a consensus optimal should be reached best outcomes, based further randomized controlled trials.